Yes, multiple studies have found increased cancer rates in lab rats fed aspartame, but major regulatory agencies dispute whether those findings are reliable. The debate centers on a series of large-scale rat studies conducted by Italy’s Ramazzini Institute, which reported statistically significant increases in lymphomas, leukemias, and other cancers in aspartame-fed animals. The FDA and European food safety authorities reviewed the same data and concluded the studies had serious design flaws that undermine the results.
What the Rat Studies Found
The most prominent animal research on aspartame and cancer comes from the Ramazzini Institute in Bologna, Italy, which published a series of studies beginning in the mid-2000s. In the first major study, Sprague-Dawley rats were fed aspartame at seven dose levels, ranging from zero to 100,000 parts per million in their food, starting at 8 weeks of age and continuing for their entire natural lifespan.
The rats developed malignant tumors at higher rates than control animals. The most consistent finding was a statistically significant increase in blood and lymph tissue cancers: lymphomas and leukemias both increased in exposed animals regardless of sex. Female rats also developed more kidney and ureter cancers and more breast cancers. Male rats showed increased rates of malignant nerve sheath tumors.
A follow-up study went further, starting aspartame exposure before birth. Pregnant rats were fed aspartame at doses of 20 or 100 mg per kilogram of body weight, and their offspring continued receiving it throughout life. This prenatal-to-death exposure window also produced increased cancer rates, and at doses the researchers considered closer to real human consumption levels.
Why Regulators Rejected the Results
The FDA reviewed the Ramazzini studies and concluded they did not change the agency’s safety assessment. The FDA had already evaluated over 100 aspartame studies before approving it, including two-year rat studies, lifetime rat studies, mouse studies, and dog studies. After the Ramazzini data came out, the agency also reviewed a large National Cancer Institute epidemiology study of more than 500,000 people and studies on genetically modified mice bred to be more cancer-susceptible. None of these altered the FDA’s position.
In 2023, the International Agency for Research on Cancer (IARC), part of the World Health Organization, formally evaluated aspartame. Its working group acknowledged that the Ramazzini studies showed carcinogenic activity in rats, but raised serious concerns about the research quality. The studies were not conducted under Good Laboratory Practices, a set of standardized protocols that ensure consistency and reliability. The researchers also did not adjust for “litter effects,” a statistical issue that arises when pups from the same mother are treated as independent data points when they’re not. IARC ultimately classified aspartame as “possibly carcinogenic to humans,” its third-highest category, which reflects limited rather than convincing evidence.
The Sprague-Dawley rat strain used in the Ramazzini studies is also a point of contention. These rats are known to develop high background rates of lymphomas and other tumors as they age, which makes it harder to determine whether aspartame specifically caused the observed cancers or whether the natural tumor rate in aging animals skewed the data.
How the Doses Compare to Human Consumption
The FDA’s acceptable daily intake for aspartame is 50 mg per kilogram of body weight. For a 150-pound person, that works out to roughly 15 to 18 cans of diet soda per day, depending on the brand. Most people consume far less than this threshold.
The highest dose in the first Ramazzini study, 100,000 ppm in feed, was far above what any human would consume. But the follow-up prenatal study used doses of 20 and 100 mg/kg, which are within the range of the FDA’s daily limit. The researchers specifically designed those lower doses to be more relevant to human exposure, and they still reported increased cancer rates. Critics counter that even at these doses, the study design problems make the results unreliable.
The Formaldehyde Question
One proposed explanation for how aspartame might cause cancer involves its breakdown in the body. When you consume aspartame, your digestive system splits it into three components: two amino acids and a small amount of methanol. That methanol is further converted into formaldehyde, a known carcinogen.
A study using radiolabeled aspartame (tagged so researchers could track where it went) found that formaldehyde derived from aspartame binds directly to proteins and DNA in rat tissues. When rats were given 10 mg/kg of labeled aspartame, researchers detected a distinct, abnormal chemical mark on their DNA that wasn’t present in unexposed animals. More concerning, when rats were pre-treated with unlabeled aspartame for 10 days before receiving the tracked dose, even more formaldehyde-DNA binding was detected. This suggests the damage may be cumulative over time.
The amount of formaldehyde produced from a typical serving of aspartame is small, and your body also produces formaldehyde from other foods, including fruit juice and tomatoes. The question is whether the specific pattern of formaldehyde release from regular aspartame consumption creates enough DNA damage to matter. That question remains unresolved.
Where the Evidence Stands
The honest answer is that aspartame has caused cancer in some rat studies, but the scientific community is genuinely divided on what those results mean. The Ramazzini findings are not trivial: they showed dose-dependent increases in multiple tumor types across several studies, with statistical significance. But the methodological criticisms are also not trivial. Studies that lack standardized lab practices and proper statistical controls carry less weight in regulatory risk assessment.
Large human studies have generally not found a clear link between aspartame consumption and cancer at typical intake levels. The FDA, the European Food Safety Authority, and the joint WHO/FAO expert committee on food additives all maintain that aspartame is safe at current approved levels. IARC’s “possibly carcinogenic” classification puts aspartame in the same category as aloe vera extract and pickled vegetables, a category that signals uncertainty rather than confirmed danger.